Mkts

Altimmune, Inc.

NASDAQ: ALT
$1.32-0.09 (-6.38%)
As of Nov 20, 9:30 AM ET

Key statistics

Day range
1.321.46
52-week range
1.326.44
Today
Open1.37
Previous close1.32
Volume4.02M
Valuation
Market cap262.70M
P/E ratio—
EPS (TTM)-0.78
Income & risk
Dividend / yield—
Beta0.33
Avg volume5.07M
Discussion

ALT News

Stories mentioning ALT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue26.005.005.005.005.005.005.00
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development16,19218,40914,96017,23615,82719,78119,80321,155
Sales General & Admin
Total Operating Expenses24,24428,91920,86422,92721,82024,87124,77226,750
Operating Income (Loss)(24,244)(28,893)(20,859)(22,922)(21,815)(24,866)(24,767)(26,745)
Interest Income2,9012,4382,4261,1321,5451,5691,9102,182
Interest Expense
Other Expense(152.00)(27.00)(86.00)(92.00)15.00118.0018.00(76.00)
Pretax Income(22,563)(27,358)(19,014)(22,146)(20,256)(23,180)(22,845)(24,640)
Tax Provision(681.00)0.000.00
Net Income (Loss)(22,563)(27,358)(19,014)(22,146)(19,575)(23,180)(22,845)(24,640)
Earnings Per Share (Basic)(0.18)(0.31)(0.21)(0.27)(0.26)(0.33)(0.32)(0.35)
Earnings Per Share (Diluted)(0.18)(0.31)(0.21)(0.27)(0.26)(0.33)(0.32)(0.35)
Weighted Average Shares Outstanding (Basic)124,46288,10489,41881,47875,54871,00371,08570,924
Weighted Average Shares Outstanding (Diluted)124,46288,10489,41881,47875,54871,00371,08570,924

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ALT

Altimmune, Inc. (NASDAQ: ALT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALT. It last traded at $1.32 (Nov 20, 2026, 9:30 AM ET), down 6.4% on the day. That gives Altimmune a market capitalisation of $262.7M.

Over the past 52 weeks ALT has traded between $1.32 and $6.44.

For the quarter ended Mar 31, 2026 it reported a net loss of $22.6M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$22.6M—
Dec 31, 2025$26.0K-$27.4M-105223.1%
Sep 30, 2025$5.0K-$19.0M-380280.0%
Jun 30, 2025$5.0K-$22.1M-442920.0%

From Altimmune’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…